Literature DB >> 29233016

The association between the metabolic syndrome and metabolic syndrome score and pulmonary function in non-smoking adults.

Hyun Yoon1, Mi Young Gi2, Ju Ae Cha3, Chan Uk Yoo4, Sang Muk Park5.   

Abstract

OBJECTIVE: This study assessed the association of metabolic syndrome and metabolic syndrome score with the predicted forced vital capacity and predicted forced expiratory volume in 1 s (predicted forced expiratory volume in 1 s) values in Korean non-smoking adults.
METHODS: We analysed data obtained from 6684 adults during the 2013-2015 Korean National Health and Nutrition Examination Survey.
RESULTS: After adjustment for related variables, metabolic syndrome ( p < 0.001) and metabolic syndrome score ( p < 0.001) were found to be inversely associated with the predicted forced vital capacity and forced expiratory volume in 1 s values. The odds ratios of restrictive pulmonary disease (the predicted forced vital capacity < 80.0% with forced expiratory volume in 1 s/FVC ⩾ 70.0%) by metabolic syndrome score with metabolic syndrome score 0 as a reference group showed no significance for metabolic syndrome score 1 [1.061 (95% confidence interval, 0.755-1.490)] and metabolic syndrome score 2 [1.247 (95% confidence interval, 0.890-1.747)], but showed significant for metabolic syndrome score 3 [1.433 (95% confidence interval, 1.010-2.033)] and metabolic syndrome score ⩾ 4 [1.760 (95% confidence interval, 1.216-2.550)]. In addition, the odds ratio of restrictive pulmonary disease of the metabolic syndrome [1.360 (95% confidence interval, 1.118-1.655)] was significantly higher than those of non-metabolic syndrome.
CONCLUSION: Metabolic syndrome and metabolic syndrome score were inversely associated with the predicted forced vital capacity and forced expiratory volume in 1 s values in Korean non-smoking adults. In addition, metabolic syndrome and metabolic syndrome score were positively associated with the restrictive pulmonary disease.

Entities:  

Keywords:  Metabolic syndrome; metabolic syndrome score; non-smoker; pulmonary function; restrictive pulmonary diseases

Mesh:

Year:  2017        PMID: 29233016     DOI: 10.1177/1479164117746022

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  2 in total

1.  Fine-Mapping of the PLCL2 Gene Identifies Candidate Variants Associated With Ischaemic Stroke Risk in Metabolic Syndrome Patients.

Authors:  Xiaoya Huang; Qiang Ye; Yanlei Zhang; Yanyan Chen; Jia Li; Jun Sun; Zusen Ye
Journal:  Front Neurol       Date:  2022-01-20       Impact factor: 4.003

2.  High-Density Lipoprotein Cholesterol: A Component of the Metabolic Syndrome with a New Role in Lung Function.

Authors:  Faxuan Wang; Di Tian; Yi Zhao; Jiangping Li; Xiyuan Chen; Yuhong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-02       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.